Search results
Bio-Rad Laboratories (BIO) to Post Q1 Earnings: What Awaits?
Zacks via Yahoo Finance· 2 hours agoThe ongoing weakness in the biopharma end markets and tightening of sanctions against Russia is...
Why Is Bio-Path (BPTH) Stock Up 89% Today?
InvestorPlace· 1 hour agoBio-Path (NASDAQ:BPTH) stock is rising higher on Thursday after the oncology company announced an update on its Phase 1/1b clinical trial of BP1002. This...
EVOTEC AND VARIANT BIO ENTER STRATEGIC PARTNERSHIP TO DISCOVER AND DEVELOP FIBROSIS TREATMENTS
WPRI Providence· 4 hours agoEvotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) and Variant Bio, Inc. today announced a collaboration agreement to identify a best-in-class ...
Equities Analysts Issue Forecasts for Gritstone bio, Inc.’s Q1 2024 Earnings (NASDAQ:GRTS)
ETF DAILY NEWS· 10 hours agoGritstone bio, Inc. (NASDAQ:GRTS – Free Report) – Equities researchers at B. Riley issued their Q1 2024 earnings estimates for Gritstone bio in a report ...
Bio-Path Holdings Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1b...
Morningstar· 5 hours agoBio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted ...
Tourmaline Bio, Inc. (NASDAQ:TRML) Given Average Recommendation of “Buy” by Analysts
ETF DAILY NEWS· 13 hours agoTourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) has earned an average recommendation of “Buy” from the six ratings firms that are currently covering the firm, MarketBeat.com ...
Form Bio Establishes Scientific Advisory Board, Comprised of Renowned Experts in Cell and Gene...
Digital Journal· 4 hours agoVector Engineering, Viral Vector Delivery Systems and Next-Generation Gene Transfer Technologies Further Cements Form Bio's Position as a Leader in AI-Driven Cell and Gene ...
Bio-Rad (BIO) Hurt by Softness in BioPharma and Competition
Zacks via Yahoo Finance· 2 days agoBio-Rad BIO has been facing the impact of funding issues in the biopharmaceutical or BioPharma...
Bio-Path Holdings, Inc. (NASDAQ:BPTH) Sees Significant Growth in Short Interest
ETF DAILY NEWS· 13 hours agoBio-Path Holdings, Inc. (NASDAQ:BPTH – Get Free Report) was the target of a significant growth in short interest during the month of March. As of March 31st, there was short ...
Bio-Rad Laboratories (NYSE:BIO shareholders incur further losses as stock declines 14% this week,...
Simply Wall St. via Yahoo Finance· 1 day agoInvesting in stocks inevitably means buying into some companies that perform poorly. Long term Bio...